Enterprise HL7 / FHIR Terminology Engine
Universal Clinical Codes & Terminology Search
Search, verify, and inspect standardized LOINC, SNOMED CT, ICD-10-CM, RxNorm, and CPT clinical codes with native HL7 FHIR R4 resource mappings.
Showing 20 of 23669 codes
Per page:
Need to map or validate codes in bulk?
Cross-reference up to 1,000 ICD-10, LOINC, and CPT records simultaneously in memory with our free utility.
| Code Value | Display Description | Code System & OID | FHIR Resource | Category | Status | Actions |
|---|---|---|---|---|---|---|
|
05SV0ZZ
|
Reposition Left Face Vein Open Approach
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
05SV3ZZ
|
Reposition Left Face Vein Percutaneous Approach
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
05SV4ZZ
|
Reposition Left Face Vein Percutaneous Endoscopic Approach
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
05SY0ZZ
|
Reposition Upper Vein Open Approach
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
05SY3ZZ
|
Reposition Upper Vein Percutaneous Approach
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
05SY4ZZ
|
Reposition Upper Vein Percutaneous Endoscopic Approach
|
ICD-10-PCS
2.16.840.1.113883.6.4
|
Procedures | Procedures | Active |
|
|
0600U
|
Infectious disease (wound infection) identification of 65 organisms and 30 antibiotic resistance genes wound swab real-time PCR reported as positive or negative for each organism
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0603U
|
Drug assay presumptive 77 drugs or metabolites urine liquid chromatography with tandem mass spectrometry (LC-MS/MS) results reported as positive or negative
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0610U
|
Infectious disease (antimicrobial susceptibility) phenotypic antimicrobial susceptibility testing of positive blood culture using microfluidic sensor technology to quantify bacterial growth response to multiple antibiotic types reporting categorical susceptibility (susceptible susceptible dose dependent intermediate resistant) minimum inhibitory concentration and interpretive comments
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0616U
|
Neurology (dementia) DNA methylation analysis of more than 30000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0617U
|
Cardiovascular (atherosclerotic cardiovascular disease [ASCVD]) DNA methylation analysis of more than 20000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0618U
|
Psychiatry (bipolar disorder) DNA methylation analysis of more than 10000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0619U
|
Pulmonary (chronic obstructive pulmonary disease [COPD]) DNA methylation analysis of more than 18000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0620U
|
Oncology (hepatocellular carcinoma) DNA methylation analysis of more than 5000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0621U
|
Infectious disease (Lyme borreliosis) DNA methylation analysis of more than 10000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0622U
|
Psychiatry (major depressive disorder) DNA methylation analysis of more than 20000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0623U
|
Autoimmune (multiple sclerosis) DNA methylation analysis of more than 5000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0624U
|
Hepatology (nonalcoholic steatohepatitis [NASH]) DNA methylation analysis of 5000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0625U
|
Endocrinology (osteoporosis) DNA methylation analysis of more than 5000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
|
0626U
|
Neurology (Parkinson disease) DNA methylation analysis of more than 20000 sites whole blood algorithm reported as positive or negative risk
|
CPT
2.16.840.1.113883.6.12
|
Procedures | Procedures | Active |
|
Healthcare Terminology & FHIR R4 Interoperability
Standardized coding guidelines governed by CodesForMD
In HL7 FHIR R4, discrete clinical findings and laboratory measurements are encapsulated inside
Observation resources. Diagnostic terms and problem list entries are represented within Condition resources, while surgical and therapeutic acts map to Procedure. CodesForMD adheres to official US Core and International FHIR Implementation Guides.
An OID is an internationally standardized dotted-decimal identifier (e.g.
2.16.840.1.113883.6.1 for LOINC) registered with HL7 and ISO. OIDs ensure unambiguous identification of terminology authorities when exchanging clinical messages across heterogeneous EHR, LIS, and PACS systems.
Yes. You can visit our platform's administrative ingestion and export engine or contact our team to obtain batch files of standardized codes.